ALKERMES reported $3.55M in Interest Expense on Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Amgen AMGN:US USD 368M 40M
Biogen BIIB:US USD 59.9M 5.9M
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
Bristol Myers Squibb BMY:US USD 299M 14M
Eli Lilly And LLY:US USD 81.5M 300K
Gilead Sciences GILD:US USD 229M 13M
IONIS PHARMACEUT IONS:US USD 2.14M 9K
JAZZ PHA JAZZ:US USD 83.74M 19.86M
Marinus Pharmaceuticals MRNS:US USD 2.63M 22K
Nektar Therapeutics NKTR:US USD 6.95M 275K
Neurocrine Biosciences NBIX:US USD 1.2M 1000K
Pfizer PFE:US USD 311M 18M
Regeneron Pharmaceuticals REGN:US USD 15.3M 2.2M
Revance Therapeutics RVNC:US USD 6.92M 3.04M
Teva Pharmaceutical Industries TEVA:US USD 230M 5M
Vertex Pharmaceuticals VRTX:US USD 13.7M 900K